Results of an open, observational, non-interventional study of the efficacy and safety of etoricoxib (Dolocox) in osteoarthritis of various localizations (knee joint, hip joint) Etoricoxib (Dolocox) Observational Study (EDONIS)”
Osteoarthritis (OA) is the most common joint disease, the first line of treatment for which are non-steroidal anti-inflammatory drugs. In terms of sufficient duration for pain relief and minimization of the risk of adverse events (AE), it seems relevant to evaluate the efficacy and safety of a short...
Saved in:
| Main Authors: | S. P. Yakupova, E. V. Zonova, E. Yu. Akulinushkina, A. S. Kabargina, E. D. Shalagina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2025-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etoricoxib for generalized osteoarthritis. Case report
by: I. S. Dydykina, et al.
Published: (2021-02-01) -
Cardiovascular safety of etoricoxib
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01) -
Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01) -
Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01) -
Etoricoxib – 15 years in Russia: the main results in the treatment of rheumatic diseases
by: N. V. Chichasova, et al.
Published: (2024-01-01)